Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Translational Oncology
|
April 16, 2014
The implications of hyponitroxia in cancer
Bryan Oronsky, Gary R Fanger, Neil Oronsky, et al.
Seminars in Oncology
|
July 29, 2020
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19
Bryan Oronsky, Susan Knox, Pedro Cabrales, et al.
Cancer Chemotherapy and Pharmacology
|
February 7, 2018
A note on improved statistical approaches to account for pseudoprogression
Nacer Abrouk, Bryan Oronsky, Scott Caroen, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 3, 2004
Dosimetry model for radioactivity localized to intestinal mucosa
Darrell Fisher, Didier Rajon, Hazel Breitz, et al.
Theranostics
|
June 20, 2013
Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm
Ramasamy Paulmurugan, Bryan Oronsky, Chad F Brouse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 9, 2017
European Breast Cancer Conference manifesto on breast centres/units
Fatima Cardoso, Luigi Cataliotti, Alberto Costa, et al.
Investigational New Drugs
|
February 5, 2016
RRx-001, A novel dinitroazetidine radiosensitizer
Bryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Discovery Medicine
|
April 27, 2016
Rockets, radiosensitizers, and RRx-001: an origin story part I
Bryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Redox Biology
|
July 13, 2015
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001
Jan Scicinski, Bryan Oronsky, Shoucheng Ning, et al.
The British Journal of Nutrition
|
November 22, 2012
Vitamin D in pregnancy at high latitude in Scotland
Paul Haggarty, Doris M Campbell, Susan Knox, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Translational Oncology
|
April 16, 2014
The implications of hyponitroxia in cancer
Bryan Oronsky, Gary R Fanger, Neil Oronsky, et al.
Seminars in Oncology
|
July 29, 2020
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19
Bryan Oronsky, Susan Knox, Pedro Cabrales, et al.
Cancer Chemotherapy and Pharmacology
|
February 7, 2018
A note on improved statistical approaches to account for pseudoprogression
Nacer Abrouk, Bryan Oronsky, Scott Caroen, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 3, 2004
Dosimetry model for radioactivity localized to intestinal mucosa
Darrell Fisher, Didier Rajon, Hazel Breitz, et al.
Theranostics
|
June 20, 2013
Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm
Ramasamy Paulmurugan, Bryan Oronsky, Chad F Brouse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 9, 2017
European Breast Cancer Conference manifesto on breast centres/units
Fatima Cardoso, Luigi Cataliotti, Alberto Costa, et al.
Investigational New Drugs
|
February 5, 2016
RRx-001, A novel dinitroazetidine radiosensitizer
Bryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Discovery Medicine
|
April 27, 2016
Rockets, radiosensitizers, and RRx-001: an origin story part I
Bryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Redox Biology
|
July 13, 2015
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001
Jan Scicinski, Bryan Oronsky, Shoucheng Ning, et al.
The British Journal of Nutrition
|
November 22, 2012
Vitamin D in pregnancy at high latitude in Scotland
Paul Haggarty, Doris M Campbell, Susan Knox, et al.
Page
of 4